Press "Enter" to skip to content

New patent for Am Regent drug MULTRYS

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MULTRYS
Annual Drug Patent Expirations for MULTRYS

Multrys is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has seven patent family members in seven countries.

The generic ingredient in MULTRYS is cupric sulfate; manganese sulfate; selenious acid; zinc sulfate. One supplier is listed for this compound. Additional details are available on the cupric sulfate; manganese sulfate; selenious acid; zinc sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions